29 April 2017
News and Views
Links and Services
March's issue of the Alimentary Pharmacology & Therapeutics compares rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma.
There is no consensus on the standard treatment of gastric mucosa-associated lymphoid tissue (MAL
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors